Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Matteo Giovanni Della Porta, Esther Natalie Olíva et al.|Journal of Clinical Oncology|2023Cited by 109
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Gastone Castellani, Erica Travaglino et al.|Blood|2021Cited by 72
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort studyGiulia Maggioni, Uwe Platzbecker, Esther Natalie Olíva et al.|The Lancet Haematology|2022Cited by 34
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes (MDS)Cristina Astrid Tentori, Najla H. Al Ali, Elena Riva et al.|Blood|2023Cited by 5
Combining Gene Mutation with Transcriptomic Data Improves Outcome Prediction in Myelodysplastic SyndromesElisabetta Sauta, Matteo Giovanni Della Porta, Elena Riva et al.|Blood|2023Cited by 2